Annual Cash & Cash Equivalents
$93.00 K
-$344.00 K-78.72%
December 1, 2023
Summary
- As of February 8, 2025, KAPA annual cash & cash equivalents is $93.00 thousand, with the most recent change of -$344.00 thousand (-78.72%) on December 1, 2023.
- During the last 3 years, KAPA annual cash & cash equivalents has risen by +$78.70 thousand (+550.35%).
- KAPA annual cash & cash equivalents is now -78.72% below its all-time high of $437.00 thousand, reached on December 1, 2022.
Performance
KAPA Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$3.22 M
+$3.20 M+15219.05%
September 30, 2024
Summary
- As of February 8, 2025, KAPA quarterly cash and cash equivalents is $3.22 million, with the most recent change of +$3.20 million (+15219.05%) on September 30, 2024.
- Over the past year, KAPA quarterly cash and cash equivalents has increased by +$3.12 million (+3359.14%).
- KAPA quarterly cash and cash equivalents is now at all-time high.
Performance
KAPA Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
KAPA Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -78.7% | +3359.1% |
| 3 y3 years | +550.4% | - |
| 5 y5 years | +550.4% | - |
KAPA Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -78.7% | +27.4% | at high | >+9999.0% |
| 5 y | 5-year | -78.7% | +550.4% | at high | >+9999.0% |
| alltime | all time | -78.7% | +550.4% | at high | >+9999.0% |
Kairos Pharma Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $3.22 M(>+9900.0%) |
| Jun 2024 | - | $21.00 K(-47.5%) |
| Mar 2024 | - | $40.00 K(-57.0%) |
| Dec 2023 | $93.00 K | $93.00 K(-6.1%) |
| Sep 2023 | - | $99.00 K(-57.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $232.00 K(-35.0%) |
| Mar 2023 | - | $357.00 K(-18.3%) |
| Dec 2022 | $437.00 K(+498.6%) | $437.00 K |
| Dec 2021 | $73.00 K(+410.5%) | - |
| Dec 2020 | $14.30 K | - |
FAQ
- What is Kairos Pharma annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Kairos Pharma?
- What is Kairos Pharma annual cash & cash equivalents year-on-year change?
- What is Kairos Pharma quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Kairos Pharma?
- What is Kairos Pharma quarterly cash and cash equivalents year-on-year change?
What is Kairos Pharma annual cash & cash equivalents?
The current annual cash & cash equivalents of KAPA is $93.00 K
What is the all time high annual cash & cash equivalents for Kairos Pharma?
Kairos Pharma all-time high annual cash & cash equivalents is $437.00 K
What is Kairos Pharma annual cash & cash equivalents year-on-year change?
Over the past year, KAPA annual cash & cash equivalents has changed by -$344.00 K (-78.72%)
What is Kairos Pharma quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of KAPA is $3.22 M
What is the all time high quarterly cash and cash equivalents for Kairos Pharma?
Kairos Pharma all-time high quarterly cash and cash equivalents is $3.22 M
What is Kairos Pharma quarterly cash and cash equivalents year-on-year change?
Over the past year, KAPA quarterly cash and cash equivalents has changed by +$3.12 M (+3359.14%)